PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Instituto de Ortopedia e Traumatologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP 01246-903, Brazil; Sport Traumatology Group, Department of Orthopaedics and Traumatology, Santa Casa de São Paulo School of Medical Sciences , São Paulo, SP 01221-020, Brazil. Electronic address: pedro.oliveira@fm.usp.br.\', \'Centro de Investigação Translacional em Oncologia, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP 01246-000, Brazil.\', \'Department of Microbiology, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP 05508-900, Brazil.\', \'Department of Immunology, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP 05508-900, Brazil.\', \'Laboratório de Biologia Vascular e Aterosclerose (Aterolab), Faculdade de Ciências Médicas da UNICAMP, Campinas, SP 13083-887, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0306-9877(20)31182-810.1016/j.mehy.2020.109920
?:doi
?:hasPublicationType
?:journal
  • Medical hypotheses
is ?:pmid of
?:pmid
?:pmid
  • 32534337
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.443
?:rankingScore_hIndex
  • 75
is ?:relation_isRelatedTo_publication of
?:title
  • Diacerein: A potential multi-target therapeutic drug for COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32534337>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32534337>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all